“The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients Who Can Forego Sentinel Lymph Node Biopsy When Applying NCCN Guidelines”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): 474-81. https://doi.org/10.25251/skin.6.6.4.